Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02011269

TSO for Plaque Psoriasis

A Randomized, Blinded, Placebo-controlled Multicenter Study to Assess the Safety and Efficacy of Trichuris Suis Ova for the Treatment of Moderate to Severe Chronic Plaque Psoriasis

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Coronado Biosciences, Inc. · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This is a randomized, blinded, multicenter study to assess the safety and treatment effect of 12 weeks of Trichuris suis ova in subjects diagnosed with moderate to severe chronic plaque psoriasis.

Conditions

Interventions

TypeNameDescription
BIOLOGICALTrichuris Suis Ova

Timeline

Start date
2014-03-01
Primary completion
2015-01-01
First posted
2013-12-13
Last updated
2015-05-06

Source: ClinicalTrials.gov record NCT02011269. Inclusion in this directory is not an endorsement.